FindTrial
Sign In

Assessment of remaining substances in used liquids of human embryos

Estimation of residual cryoprotectants from spent thawing solutions of human embryos - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085908
Enrollment
100
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

SAR Healthline Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Couples who are undergoing frozen embryo transfer (FET)

Exclusion criteria

Exclusion criteria: Couples who have opted for fresh embryo transfer

Design outcomes

Primary

MeasureTime frame
To estimate residual cryoprotectants from spent thawing solutions of human embryosTimepoint: 1 year—

Secondary

MeasureTime frame
Development of new cryopreservation media for human embryos as well as establishment of new protocol which allows proper removal of cryoprotectants during the warming of human embryos.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Satish Kumar Adiga

Kasturba Medical College, Manipal, Manipal Academy of Higher Education Manipal

satish.adiga@manipal.edu9945671115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026